Parabolic Drugs Ltd.
| BSE: 533211 | Sector: Health care |
| NSE: PARABDRUGS | ISIN Code: INE618H01016 |
| BSE 00:00 | 11 Aug | 2.12 |
0 (0.00%) |
OPEN
2.15 |
HIGH
2.25 |
LOW
2.05 |
| NSE 09:42 | 12 Aug | 2.30 |
0.10 (4.55%) |
OPEN
2.30 |
HIGH
2.30 |
LOW
2.30 |
| OPEN | 2.15 |
| PREVIOUS CLOSE | 2.12 |
| VOLUME | 33813 |
| 52-Week high | 4.73 |
| 52-Week low | 0.70 |
| P/E | |
| Mkt Cap.(Rs cr) | 13 |
| Buy Price | 2.10 |
| Buy Qty | 21101.00 |
| Sell Price | 2.25 |
| Sell Qty | 1.00 |
Parabolic Drugs Ltd. (PARABDRUGS) - Announcements
-
Parabolic Drugs Ltd Disclosure Regarding Of Impact Of Covid-19 Pandemic On Listed Entities Under SEBI (Listing Obligatio
01/08/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
30/07/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
24/07/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Outcome Of Board Meeting
17/07/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Board Meeting Intimation for Declaration Of Un-Audited Financial Results And Notice Regarding Closur
10/07/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Shareholding for the Period Ended June 30 2020
09/07/2020 | bse
-
Parabolic Drugs Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09/07/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Statement Of Investor Complaints For The Quarter Ended June 2020
09/07/2020 | bse
-
Parabolic Drugs Ltd Shareholding for the Period Ended December 31 2019
20/06/2020 | bse
-
Parabolic Drugs Ltd Shareholding for the Period Ended September 30 2019
20/06/2020 | bse
-
Parabolic Drugs Ltd Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations & Disclosure Requirements)
19/06/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
19/06/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
16/06/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Reg
16/06/2020 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Shareholding for the Period Ended March 31 2020
12/06/2020 | bse
-
Parabolic Drugs Ltd Statement Of Investor Complaints For The Quarter Ended March 2020
12/06/2020 | bse
-
Parabolic Drugs Ltd Results For Quarter Ended 30/06/2019
14/08/2019 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Results For Quarter Ended 30/06/2019
14/08/2019 | bse |
Downlaod PDF -
Parabolic Drugs Ltd Shareholding for the Period Ended June 30 2019
19/07/2019 | bse
-
Parabolic Drugs Ltd Statement Of Investor Complaints For The Quarter Ended June 2019
15/07/2019 | bse
Quick Links for Parabolic Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
